Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inhibrx Biosciences Inc.

    NASDAQ: INBX · Real-Time Price · USD
    23.52
    -0.42 (-1.75%)
    At close: Aug 15, 2025, 12:51 PM

    Inhibrx Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 152.6M 277.92M 273.87M 131.3M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 6.83M 3.16M 3.16M 1.85M
    Receivables
    		 420K 778K 257K 878K
    Inventory
    		 n/a n/a -257K -878K
    Other Current Assets
    		 816K 366K 1.3M 7.81M
    Total Current Assets
    		 160.4M 295.36M 280.49M 139.11M
    Property-Plant & Equipment
    		 13.54M 9.37M 7.22M 9.49M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 20.37M 12.54M 10.38M 11.34M
    Total Assets
    		 180.77M 307.89M 290.88M 150.45M
    Account Payables
    		 9.24M 8.31M 4.34M 9.13M
    Deferred Revenue
    		 n/a n/a 166K 2.03M
    Short-Term Debt
    		 1.59M 2.06M 1.86M 1.67M
    Other Current Liabilities
    		 22.16M 37.37M 15.97M 9.62M
    Total Current Liabilities
    		 40.73M 56.31M 27.58M 22.45M
    Long-Term Debt
    		 6.45M 206.97M 202.07M 75.5M
    Other Long-Term Liabilities
    		 n/a n/a 3.17M 110K
    Total Long-Term Liabilities
    		 6.45M 208.08M 205.24M 75.61M
    Total Liabilities
    		 47.18M 264.39M 232.82M 98.07M
    Total Debt
    		 8.05M 210.14M 207.1M 77.18M
    Common Stock
    		 1K 5K 4K 4K
    Retained Earnings
    		 -106.13M -613.73M -372.37M -227.15M
    Comprehensive Income
    		 n/a n/a n/a -150.45M
    Shareholders Equity
    		 133.58M 43.5M 58.06M 52.38M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist